Covered recipient · General Payments record
ZANDRA R RIVERA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$8,093.38
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,193.17 | 14 |
| Education | $89.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $213.72 | 2 |
| PFIZER INC. | $183.62 | 2 |
| E.R. Squibb & Sons, L.L.C. | $125.01 | 1 |
| EISAI INC. | $123.63 | 1 |
| Gilead Sciences, Inc. | $121.84 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $119.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $119.83 | 1 |
| Pharmacosmos Therapeutics Inc. | $104.00 | 1 |
| ABBVIE INC. | $51.13 | 1 |
| Celgene Corporation | $48.45 | 2 |
| Incyte Corporation | $45.96 | 1 |
| Legend Biotech USA Inc. | $26.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $51.13 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108092232 | CMS |
| Celgene Corporation | $28.65 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119367 | CMS |
| Celgene Corporation | $19.80 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119369 | CMS |
| E.R. Squibb & Sons, L.L.C. | $125.01 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101364832 | CMS |
| Eisai Inc. | $123.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110825612 | CMS |
| Gilead Sciences, Inc. | $121.84 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133664066 | CMS |
| Incyte Corporation | $45.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141218718 | CMS |
| Legend Biotech USA Inc. | $26.03 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131692252 | CMS |
| PFIZER INC. | $119.21 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131903313 | CMS |
| PFIZER INC. | $64.41 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131825938 | CMS |
| Pharmacosmos Therapeutics Inc. | $104.00 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154832100 | CMS |
| SOBI, INC | $89.99 | 07/16/2024 | Education | Undisputed | 01/23/2026 | 1141423347 | CMS |
| SOBI, INC | $123.73 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141430505 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $119.94 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152289565 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $119.83 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144982586 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.